{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:49:39Z","timestamp":1780073379805,"version":"3.54.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.acra.2025.06.042","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T18:03:10Z","timestamp":1752602590000},"page":"6238-6249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal Monitoring of Lumacaftor\/Ivacaftor Response in Young Children with Cystic Fibrosis Lung Disease Using 129Xe MRI"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-7032","authenticated-orcid":false,"given":"Abdullah S.","family":"Bdaiwi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Willmering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette W.","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Monir","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raouf","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Walkup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zackary I.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2025.06.042_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-genom-090314-050024","article-title":"Cystic fibrosis and its management through established and emerging therapies","volume":"17","author":"Spielberg","year":"2016","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.acra.2025.06.042_bib2","doi-asserted-by":"crossref","unstructured":"Rowe M.S., Sorscher S.M., EJ, Cystic fibrosis, NEJM, 352, 2005, 1992\u20132001.","DOI":"10.1056\/NEJMra043184"},{"issue":"S3","key":"10.1016\/j.acra.2025.06.042_bib3","first-page":"S4","article-title":"Rapid therapeutic advances in CFTR modulator science","volume":"53","author":"Clancy","year":"2018","journal-title":"Pediatr\u00a0Pulmonol"},{"issue":"19","key":"10.1016\/j.acra.2025.06.042_bib4","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Eng J Med"},{"key":"10.1016\/j.acra.2025.06.042_bib5","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr\u00a0Pulmonol"},{"issue":"9","key":"10.1016\/j.acra.2025.06.042_bib6","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1513\/AnnalsATS.201611-935OC","article-title":"Multiple-breath washout outcomes are sensitive to inflammation and infection in children with cystic fibrosis","volume":"14","author":"Ramsey","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.acra.2025.06.042_bib7","series-title":"Imaging of cystic fibrosis lung disease and clinical interpretation, in R\u00f6Fo-Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren","author":"Wielp\u00fctz","year":"2016"},{"issue":"1","key":"10.1016\/j.acra.2025.06.042_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jpeds.2012.12.042","article-title":"Distribution of early structural lung changes due to cystic fibrosis detected with chest computed tomography","volume":"163","author":"Mott","year":"2013","journal-title":"J Pediatr"},{"issue":"9","key":"10.1016\/j.acra.2025.06.042_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMoa0901249","article-title":"Exposure to low-dose ionizing radiation from medical imaging procedures","volume":"361","author":"Fazel","year":"2009","journal-title":"N Eng J Med"},{"issue":"1","key":"10.1016\/j.acra.2025.06.042_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1148\/radiol.2511081296","article-title":"Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults","volume":"251","author":"Sodickson","year":"2009","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.acra.2025.06.042_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1164\/rccm.201309-1659OC","article-title":"Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease","volume":"189","author":"Wielputz","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.acra.2025.06.042_bib12","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1513\/AnnalsATS.202402-201OC","article-title":"Long-term impact of lumacaftor\/ivacaftor treatment on cystic fibrosis disease progression in children 2\u20135 years of age homozygous for F508del-CFTR: a phase 2, open-label clinical trial","volume":"21","author":"Stahl","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/RLI.0000000000000322","article-title":"Hyperpolarized 129Xenon magnetic resonance imaging to quantify regional ventilation differences in mild to moderate asthma: a prospective comparison between semiautomated ventilation defect percentage calculation and pulmonary function tests","volume":"52","author":"Ebner","year":"2017","journal-title":"Investig Radiol"},{"issue":"8","key":"10.1016\/j.acra.2025.06.042_bib14","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1513\/AnnalsATS.201812-880OC","article-title":"Cyst ventilation heterogeneity and alveolar airspace dilation as early disease markers in lymphangioleiomyomatosis","volume":"16","author":"Walkup","year":"2019","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.acra.2025.06.042_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/radiol.11102172","article-title":"Chronic obstructive pulmonary disease: safety and tolerability of hyperpolarized 129Xe MR imaging in healthy volunteers and patients","volume":"262","author":"Driehuys","year":"2012","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1148\/radiol.2016152299","article-title":"Chronic obstructive pulmonary disease: lobar analysis with hyperpolarized 129Xe MR imaging","volume":"282","author":"Matin","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcf.2016.07.008","article-title":"Hyperpolarized 129Xe for investigation of mild cystic fibrosis lung disease in pediatric patients","volume":"16","author":"Thomen","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib18","doi-asserted-by":"crossref","first-page":"1802188","DOI":"10.1183\/13993003.02188-2018","article-title":"Hyperpolarised 129Xe magnetic resonance imaging to monitor treatment response in children with cystic fibrosis","volume":"53","author":"Rayment","year":"2019","journal-title":"Eur Respir"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jcf.2024.07.002","article-title":"Quantifying abnormal alveolar microstructure in cystic fibrosis lung disease via hyperpolarized 129Xe diffusion MRI","volume":"23","author":"Bdaiwi","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"12","key":"10.1016\/j.acra.2025.06.042_bib20","first-page":"1429","article-title":"Translational applications of hyperpolarized 3He and 129Xe","volume":"27","author":"Walkup","year":"2014","journal-title":"NMR\u00a0Biomed"},{"key":"10.1016\/j.acra.2025.06.042_bib21","unstructured":"The 129Xe MRI Clinical Trials Consortium \u3008https:\/\/www.129xectc.org\/\u3009."},{"issue":"4","key":"10.1016\/j.acra.2025.06.042_bib22","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/jmri.29605","article-title":"Same-day repeatability and 28\u2013day reproducibility of Xenon MRI ventilation in children with cystic fibrosis in a multi-site trial","volume":"61","author":"Walkup","year":"2025","journal-title":"J Magn Reson Imaging,"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib23","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/j.chest.2020.12.008","article-title":"The clinical use of lung MRI in cystic fibrosis: what, now, how?","volume":"159","author":"Dournes","year":"2021","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.acra.2025.06.042_bib24","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s00247-016-3672-1","article-title":"Feasibility, tolerability and safety of pediatric hyperpolarized 129Xe magnetic resonance imaging in healthy volunteers and children with cystic fibrosis","volume":"46","author":"Walkup","year":"2016","journal-title":"Pediatr Radiol"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jcf.2020.11.019","article-title":"Sensitive structural and functional measurements and 1-year pulmonary outcomes in pediatric cystic fibrosis","volume":"20","author":"Willmering","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00441-2020","article-title":"The assessment of short and long term changes in lung function in CF using (129)Xe MRI","volume":"56","author":"Smith","year":"2020","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.acra.2018.04.024","article-title":"Hyperpolarized gas magnetic resonance imaging of pediatric cystic fibrosis lung disease","volume":"26","author":"Santyr","year":"2019","journal-title":"Acad Radiol"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jcf.2023.01.017","article-title":"Short-term structural and functional changes after airway clearance therapy in cystic fibrosis","volume":"22","author":"West","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcf.2019.03.005","article-title":"A two-center analysis of hyperpolarized 129Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials","volume":"18","author":"Couch","year":"2019","journal-title":"J Cyst Fibros Offl J Eur Cyst Fibros Soc"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib30","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/jmri.28470","article-title":"129Xe and free-breathing 1H ventilation MRI in patients with cystic fibrosis: a dual-center study","volume":"57","author":"Marshall","year":"2023","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jmri.27030","article-title":"Current state of the art MRI for the longitudinal assessment of cystic fibrosis","volume":"52","author":"Woods","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00441-2020","article-title":"The assessment of short-and long-term changes in lung function in cystic fibrosis using 129Xe MRI","volume":"56","author":"Smith","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.acra.2025.06.042_bib33","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jmri.29627","article-title":"Quantifying spatial distribution of ventilation defects in multiple pulmonary diseases with hyperpolarized 129Xenon MRI","volume":"61","author":"Bdaiwi","year":"2024","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1513\/AnnalsATS.201609-689OC","article-title":"Lumacaftor\/ivacaftor treatment of patients with cystic fibrosis heterozygous for F508del-CFTR","volume":"14","author":"Rowe","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"10.1016\/j.acra.2025.06.042_bib35","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respiratory Soc"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib37","first-page":"492","article-title":"Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on lung volume measurements. Official statement of The European Respiratory Society","volume":"8","author":"Stocks","year":"1995","journal-title":"Eur\u00a0Respir\u00a0J"},{"key":"10.1016\/j.acra.2025.06.042_bib38","article-title":"A dual loop T\/R -Xenon coil for homogenous excitation with improved comfort and size","author":"Loew","year":"2016","journal-title":"ISMRM"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/mrm.29655","article-title":"B1 and magnetization decay correction for hyperpolarized 129Xe lung imaging using sequential 2D spiral acquisitions","volume":"90","author":"Bdaiwi","year":"2023","journal-title":"Magn Reson Med"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib40","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/mrm.30347","article-title":"129Xe image processing pipeline: an open-source, graphical user interface application for the analysis of hyperpolarized 129Xe MRI","volume":"93","author":"Bdaiwi","year":"2025","journal-title":"Magn Reson Med"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib41","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","article-title":"N4ITK: improved N3 bias correction","volume":"29","author":"Tustison","year":"2010","journal-title":"IEEE Trans Med Imaging"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(16)30427-1","article-title":"Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study","volume":"5","author":"Konstan","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.acra.2025.06.042_bib44","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.acra.2025.06.042_bib45","doi-asserted-by":"crossref","first-page":"L432","DOI":"10.1152\/ajplung.00461.2017","article-title":"Lumacaftor (VX-809) restores the ability of CF macrophages to phagocytose and kill Pseudomonas aeruginosa","volume":"314","author":"Barnaby","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00731-2020","article-title":"Lumacaftor\/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients","volume":"7","author":"Neerincx","year":"2021","journal-title":"ERJ Open Res"},{"issue":"5","key":"10.1016\/j.acra.2025.06.042_bib47","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/mrm.29982","article-title":"Estimating ventilation correlation coefficients in the lungs using PREFUL-MRI in chronic obstructive pulmonary disease patients and healthy adults","volume":"91","author":"Moher Alsady","year":"2024","journal-title":"Magn Reson Med"},{"issue":"6","key":"10.1016\/j.acra.2025.06.042_bib48","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1007\/s00330-023-10395-8","article-title":"Long-term pulmonary outcome of children with congenital diaphragmatic hernia: functional lung MRI using matrix-pencil decomposition enables side-specific assessment of lung function","volume":"34","author":"Streibel","year":"2024","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.acra.2025.06.042_bib49","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mrm.30299","article-title":"Comparison of 3D UTE free-breathing lung MRI with hyperpolarized 129Xe MRI in pediatric cystic fibrosis","volume":"93","author":"Munidasa","year":"2025","journal-title":"Magn Reson Med"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225006221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633225006221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T22:27:47Z","timestamp":1763677667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633225006221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1076633225006221"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2025.06.042","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Monitoring of Lumacaftor\/Ivacaftor Response in Young Children with Cystic Fibrosis Lung Disease Using 129Xe MRI","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2025.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}